Assignee
CELLTRION INC
KR·30 granted patents·17 pending applications·22 citations·filing 2009–2024
Top patents by PatentIndex Score
47 records- 0191US10980881B2Stable liquid formula having an anti-TNFalpha antibody, acetate buffer and glycineCELLTRION INC·Filed 2018·Granted Apr 20, 2021·7 cites·20 claims
- 0285US11986523B2Stable liquid formula comprising anti-TNFa antibody, acetate buffer, and glycineCELLTRION INC·Filed 2021·Granted May 21, 2024·1 cites·14 claims
- 0379US9834594B2Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A virusesCELLTRION INC·Filed 2017·Granted Dec 5, 2017·2 cites·23 claims
- 0478US9856312B2Binding molecule having influenza A virus-neutralizing activity produced from human B cellCELLTRION INC·Filed 2016·Granted Jan 2, 2018·3 cites·13 claims
- 0577US9814784B2Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing sameCELLTRION INC·Filed 2014·Granted Nov 14, 2017·2 cites·24 claims
- 0677US2024358827A1Stable liquid formulaCELLTRION INC·Filed 2024·Application pending·0 cites
- 0775US9278996B2Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the sameCELLTRION INC·Filed 2013·Granted Mar 8, 2016·2 cites·14 claims
- 0875US2024269069A1Stable liquid pharmaceutical preparationCELLTRION INC·Filed 2024·Application pending·0 cites
- 0975US2024269071A1Stable liquid pharmaceutical preparationCELLTRION INC·Filed 2024·Application pending·0 cites
- 1072US12188036B2Expression cassette for production of high-expression and high-functionality target protein and use thereofCELLTRION INC·Filed 2018·Granted Jan 7, 2025·1 cites·8 claims
- 1170US9475861B2Binding molecule having influenza A virus-neutralizing activity produced from human B cellCELLTRION INC·Filed 2012·Granted Oct 25, 2016·2 cites·16 claims
- 1270US2025002573A1Methods for Treating TNFa-Related DiseasesCELLTRION INC·Filed 2024·Application pending·0 cites
- 1370US2025084433A1Expression Cassette for Production of High-Expression and High-Functionality Target Protein and Use ThereofCELLTRION INC·Filed 2024·Application pending·0 cites
- 1469US10703802B2Composition comprising at least two influenza A virus-neutralizing-binding moleculesCELLTRION INC·Filed 2014·Granted Jul 7, 2020·1 cites·25 claims
- 1568US10722571B2Rabies virus G protein epitope, and rabies virus neutralising binding molecule that binds specifically theretoCELLTRION INC·Filed 2016·Granted Jul 28, 2020·1 cites·15 claims
- 1664US11951207B2Stable liquid pharmaceutical preparationCELLTRION INC·Filed 2017·Granted Apr 9, 2024·0 cites·14 claims
- 1759US12534738B2Expression cassette including intron for high expression of protein of interest and use thereofCELLTRION INC·Filed 2020·Granted Jan 27, 2026·0 cites·13 claims
- 1858US12419863B2Pharmaceutical composition for use in treatment of hypertrophic cardiomyopathyCELLTRION INC·Filed 2019·Granted Sep 23, 2025·0 cites·11 claims
- 1958US11730698B2Stable liquid pharmaceutical preparationCELLTRION INC·Filed 2019·Granted Aug 22, 2023·0 cites·25 claims
- 2058US2025266155A1Clinical Supplies Management Method And Device Using SameCELLTRION INC·Filed 2021·Application pending·0 cites
- 2156US11236146B2Stable pharmaceutical formulationCELLTRION INC·Filed 2017·Granted Feb 1, 2022·0 cites·13 claims
- 2254US11202751B2Whitening cosmetic composition comprising Caragana sinica root extractCELLTRION INC·Filed 2016·Granted Dec 21, 2021·0 cites·2 claims
- 2354US10947497B2Nelumbo nucifera callus extract having increased content of gallic acid, method for preparing same, and whitening cosmetic composition containing sameCELLTRION INC·Filed 2017·Granted Mar 16, 2021·0 cites·5 claims
- 2454US10610587B2Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing sameCELLTRION INC·Filed 2018·Granted Apr 7, 2020·0 cites·4 claims
- 2554US2020390842A1Composition for alleviating skin inflammation caused by yellow dust and fine particulate, comprising natural plant extractCELLTRION INC·Filed 2020·Application pending·0 cites
- 2654US2021371510A1Methods for Treating TNFa-Related DiseasesCELLTRION INC·Filed 2018·Application pending·0 cites
- 2752US12533343B2Method for preparing (−)-cibenzoline succinateCELLTRION INC·Filed 2019·Granted Jan 27, 2026·0 cites·11 claims
- 2852US2023312683A1Stable pharmaceutical preparationCELLTRION INC·Filed 2021·Application pending·0 cites
- 2950US12551465B2Pharmaceutical composition for treatment of hypertrophic cardiomyopathy and treatment method using same compositionCELLTRION INC·Filed 2021·Granted Feb 17, 2026·0 cites·14 claims
- 3049US12546779B2Binding molecule having neutralizing activity against SARS-coronavirus-2CELLTRION INC·Filed 2021·Granted Feb 10, 2026·0 cites·10 claims
- 3149US2025263468A1Binding molecule having neutralizing activity against coronavirus superfamilyCELLTRION INC·Filed 2021·Application pending·0 cites
- 3249US2023110839A1Varicella zoster virus fusion protein and immunogenic composition comprising sameCELLTRION INC·Filed 2021·Application pending·0 cites
- 3349US2022153828A1Methods for Treating TNFa-Related DiseasesCELLTRION INC·Filed 2020·Application pending·0 cites
- 3448US10239902B2Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising sameCELLTRION INC·Filed 2017·Granted Mar 26, 2019·0 cites·9 claims
- 3548US2018207222A1Composition for alleviating skin inflammation caused by yellow dust and fine particulate, comprising natural plant extractCELLTRION INC·Filed 2016·Application pending·0 cites
- 3648US2024066110A1Immunogenic Composition Comprising Multivalent Streptococcus Pneumoniae Polysaccharide-Protein ConjugatesCELLTRION INC·Filed 2022·Application pending·0 cites
- 3745US12157764B2Dosing regimen for treating influenza virus diseasesCELLTRION INC·Filed 2019·Granted Dec 3, 2024·0 cites·10 claims
- 3844US2023040902A1Pharmaceutical Formulation Comprising Cibenzoline or Salt ThereofCELLTRION INC·Filed 2020·Application pending·0 cites
- 3943US11007136B2Cosmetic composition for wrinkle reduction containing gypenoside isolated from Gynostemma pentaphyllumCELLTRION INC·Filed 2016·Granted May 18, 2021·0 cites·3 claims
- 4043US8361790B2Human host cell for producing recombinant proteins with high quality and quantityCELLTRION INC·Filed 2009·Granted Jan 29, 2013·0 cites·5 claims
- 4143US2018008702A1Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing sameCELLTRION INC·Filed 2015·Application pending·0 cites
- 4242US12065482B2Stable liquid pharmaceutical formulation of anti-influenza virus antibodyCELLTRION INC·Filed 2017·Granted Aug 20, 2024·0 cites·9 claims
- 4342US2022177552A1Binding Molecule Having Neutralizing Activity Against Middle East Respiratory Syndrome-CoronavirusCELLTRION INC·Filed 2018·Application pending·0 cites
- 4440US10351592B2Method for separating antibody isoforms using cation exchange chromatographyCELLTRION INC·Filed 2014·Granted Jul 16, 2019·0 cites·6 claims
- 4533US12486237B2Polymorphic form of (-)-cibenzoline succinateCELLTRION INC·Filed 2021·Granted Dec 2, 2025·0 cites·14 claims
- 4633US10507240B2Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virusCELLTRION INC·Filed 2015·Granted Dec 17, 2019·0 cites·3 claims
- 4730US11712407B2Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing sameCELLTRION INC·Filed 2015·Granted Aug 1, 2023·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when CELLTRION INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →